课题基金 / 基金详情

EFFICIENT SYNTHESIS OF BIOACTIVE GAMMA LACTAMS

EFFICIENT SYNTHESIS OF BIOACTIVE GAMMA LACTAMS
生物活性γ内酰胺的高效合成
批准号:
6828276
负责人:
KYUNG W. JUNG
金额:
$21.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-01-10 至 2005-11-30

项目摘要

项目成果

KYUNG W. JUNG的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(首席研究员摘要)在我们的实验室里,我们有
英文摘要
DESCRIPTION: (Principal Investigator's Abstract) In our laboratories, we have discovered an efficient synthetic protocol to prepare a chiral gamma-lactam (pyrrolidinone) via a stereo- and regioselective intramolecular C-H insertion of an amide. This projected study is to extend the current methodology to various systems comprising amino acid derivatives, which are anticipated to demonstrate the feasibility, generality, and stereoselectivity of this methodology. Since our well designed templates are expected to avert most shortcomings found in the previously known methods, this research will give rise to an innovative synthetic protocol in chiral pyrrolidinone synthesis. Since pyrrolidine and pyrrolidinone skeletons are prevalent in biologically active natural products, our developed techniques will provide not only the necessary technologies but also crucial intermediates, which will be immediately useful. Various chiral gamma- lactams will be prepared from natural amino acids by utilizing our cyclization procedure, and they will be utilized for the synthesis of various natural products, which have constantly required efficient synthetic routes for mass production. Our synthetic targets encompass lactacystin, pramanicin, statine, rolipram, epolactaene, and kainic acid. These compounds and their structural analogs hold great promise as chiral drugs to cure numerous diseases such as cancer, Alzheimer's disease, epilepsy, and cardiovascular diseases. Due to their scarcity in natural sources and difficulties in total syntheses, biological studies have been hampered and further clinical trials are also far from being a reality. If the designed syntheses become successful, our efficient synthetic pathway will pave a new road to solve the limited availability of these compounds. Moreover, these salient methodologies in gamma-lactam synthesis will provide new perspectives in discovery of structurally related chiral drugs. We believe this new technology will help to advance organic synthesis, as well as to enhance the progress of related fields such as biology and medicinal chemistry, culminating in drug discovery.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
A novel synthetic route to chiral gamma-lactams from alpha-amino acids via Rh-catalyzed intramolecular C-H insertion.
通过 Rh 催化的分子内 C-H 插入从 α-氨基酸合成手性 γ-内酰胺的新路线。
DOI: 10.1021/jo0259717
发表时间: 2002
期刊: The Journal of organic chemistry
影响因子: --
作者: [Yoon,CheolHwan, Flanigan,DavidL, Chong,Byong-Don, Jung,KyungWoon]
通讯作者: Jung,KyungWoon
Glutathione, S-substituted glutathiones, and leukotriene C4 as substrates for peptidylglycine alpha-amidating monooxygenase.
谷胱甘肽、S-取代的谷胱甘肽和白三烯 C4 作为肽基甘氨酸 α-酰胺化单加氧酶的底物。
DOI: 10.1016/s0003-9861(02)00730-0
发表时间: 2003
期刊: Archives of biochemistry and biophysics
影响因子: 3.9
作者: [Miller,LauraAaron, Baumgart,LauraE, Chew,GeoffreyH, deLong,MitchellA, Galloway,LamarC, Jung,KyungWoon, Merkler,KathleenA, Nagle,AdvaitS, Poore,DerekD, Yoon,CheolHwan, Merkler,DavidJ]
通讯作者: Merkler,DavidJ
Acquisition of a 500 MHz NMR Spectrometer for the University of Southern Calif
Oxygen Promoted Pd(II) Catalysis for Medicinal Chemistry
  • 批准号:
    6916373
  • 项目类别:
  • 资助金额:
    $9.9万
  • 财政年份:
    2004
  • 负责人:
    KYUNG W. JUNG
  • 依托单位:
Oxygen Promoted Pd(II) Catalysis for Medicinal Chemistry
  • 批准号:
    6808186
  • 项目类别:
  • 资助金额:
    $25.38万
  • 财政年份:
    2004
  • 负责人:
    KYUNG W. JUNG
  • 依托单位:
Oxygen Promoted Pd(II) Catalysis for Medicinal Chemistry
海外基金